Seladelpar lysineProduct ingredient for Seladelpar

Name: Seladelpar lysine
Drug Entry: Seladelpar

Seladelpar is a peroxisome proliferator-activated receptor (PPAR)-delta (δ) agonist. Seladelpar is a single enantiomer of the R-configuration.⁵ On August 14, 2024, seladelpar was granted accelerated approval by the FDA for the treatment of primary biliary cholangitis,⁶ which is a condition associated with aberrant bile acid metabolism. Seladelpar works to block bile acid synthesis.¹

See full entry for Seladelpar
Accession Number: DBSALT003342
Structure: MOL SDF PDB SMILES InChI
Structure for Seladelpar lysine (DBSALT003342)
Synonyms: 2-[4-[[(2-R)-2-ethoxy-3-[4-(trifluoromethyl)phenoxy]propyl]thio]-2-methylphenoxy]acetic acid (1:1) lysine dihydrate / L-LYSINE (4-(((2R)-2-ETHOXY-3-(4-(TRIFLUOROMETHYL)PHENOXY)PROPYL)SULFANYL)-2-METHYLPHENOXY)ACETATE DIHYDRATE / MBX-8025 lysine / MBX-8025 lysine dihydrate / MBX-8025 lysine salt, dihydrate / Seladelpar lysine dihydrate